Nonmelanocytic Skin and Soft Tissue Tumors

TL;DR: Nonmelanocytic Skin & Soft Tissue Tumors

Nonmelanocytic skin and soft tissue tumors are diverse growths originating from various skin layers and associated soft tissues, excluding melanomas. This comprehensive guide, perfect for students, explores their classification, diagnosis methods like inspection, dermoscopy, and advanced imaging, and a wide array of treatment options from surgery to targeted therapies. We'll cover both common benign lesions such as epidermal cysts and lipomas, as well as significant malignant conditions like basal cell carcinoma, squamous cell carcinoma, and various sarcomas, providing detailed insights into their characteristics and management.

Understanding Nonmelanocytic Skin and Soft Tissue Tumors

The skin is a complex organ comprising the epidermis and dermis, alongside associated soft tissues like fat, muscles, blood vessels, and nerves. Nonmelanocytic skin and soft tissue tumors arise from these diverse cellular origins, which can be epithelial, cutaneous appendage, neural crest, or mesenchymal. This article provides a comprehensive overview of these tumors, excluding malignant melanocytic tumors, from a plastic surgeon's perspective.

Diagnosing Skin and Soft Tissue Tumors

Accurate diagnosis is crucial for effective treatment. The process involves multiple steps, starting with initial visual and tactile examination, progressing to specialized dermatological techniques, and culminating in advanced imaging and pathological confirmation.

Initial Assessment: Inspection and Palpation

Diagnosis begins with a thorough visual inspection and physical palpation of the lesion. Key information to record includes the number, shape, size, elevation, surface status (e.g., smooth, rough, ulcerative), color, hardness, alignment, site, and any subjective symptoms like pain or itching. The lesion's time course (acute, chronic, recurrent) is also important. Rapid changes in a lesion's shape, size, elevation, or color are critical indicators that warrant further investigation for potential malignancy. The color of a skin tumor can provide important diagnostic clues:

• Normal color: Often seen in tumors of epidermal origin (e.g., epidermoid cyst), mesenchymal origin (e.g., lipoma, soft fibroma), or neural crest origin (e.g., schwannoma).
• Yellow-pale yellow: Frequently associated with appendage-origin tumors like sebaceous nevus, xanthoma, or milia.
• Erythematous (reddish): Can indicate epidermal tumors (e.g., inflammatory atheroma, squamous cell carcinoma) or mesenchymal tumors (e.g., keloid, hemangioma, angiosarcoma).
• Blackish brown-black: Suggests epidermal origin (e.g., basal cell carcinoma) or neural crest origin (e.g., pigmented nevus).
• Blue: May be seen in epidermal (e.g., epidermoid cyst) or neural crest origin tumors (e.g., nevus of Ota, blue nevus).

Specialized Dermatological Techniques: Dermoscopy

Dermoscopy employs a binocular microscope to observe the skin surface, proving invaluable for diagnosing pigmented and non-pigmented lesions. It is essential for differentiating malignant melanoma from nevus and for diagnosing seborrheic keratosis, basal cell carcinoma (BCC), and vascular lesions. A two-step diagnostic algorithm is often used to first differentiate melanocytic from nonmelanocytic lesions, and then further classify nonmelanocytic lesions based on specific dermoscopic criteria.

• Criteria for melanocytic lesions: Pigment network, aggregated globules, branched streaks, homogeneous blue pigmentation, parallel pattern.
• Criteria for seborrheic keratosis: Multiple milia-like cysts, comedo-like openings, light-brown fingerprint-like structures, fissures/ridges.
• Criteria for basal cell carcinoma (BCC): Absence of pigment network, combined with arborizing vessels, leaf-like areas, large blue-gray ovoid nests, multiple blue-gray globules, spoke wheel areas, or ulceration.
• Criteria for vascular lesions: Red-blue lacunas, red-bluish to red-black homogeneous areas.

Imaging for Tumor Assessment

Advanced imaging techniques provide critical information about tumor depth, spread, and relation to surrounding structures.

• Ultrasound and Doppler Imaging: High-frequency ultrasound (20-50 MHz) is used for superficial skin lesions. For deeper lesions exceeding 20 mm, standard ultrasound (3-10 MHz) is employed to determine tumor thickness, relationship with adjacent structures, and lymph node metastasis. Color Doppler Imaging (CDI) or power Doppler imaging is useful for differentiating benign and malignant skin tumors, as 90% of malignant tumors exhibit high blood flow (3-20 cm/s), a feature rarely seen in benign ones. M-mode and duplex scanning are useful for hemangiomas and vascular malformations.
• X-ray, CT, MRI, Angiography, Scintigraphy, PET: X-rays detect calcifying lesions (e.g., pilomatricoma) and bone deformation. CT scans are superior for detecting metastatic lesions in bones, lymph nodes, and lungs, with contrast-enhanced CT useful for malignant tumors and vascular structures. MRI excels at visualizing soft tissues, with malignant tumors typically showing low-iso signal on T2-weighted images (T2WI) and low signal on T1-weighted images (T1WI). Magnetic resonance angiography (MRA) provides detailed information on hemangiomas and vascular malformations. Scintigraphy screens for metastatic lesions but has low resolution. PET scans, particularly FDG-PET, are valuable for detecting metastatic lesions and monitoring treatment, though inflammatory lesions must be excluded.

Pathologic Diagnosis and Staging

A definitive diagnosis requires a pathological examination. Biopsies should be performed with a clear purpose, such as differentiating benign tumors or determining the stage and grade of malignant tumors. Options include punch, incisional, excisional, and mapping biopsies. For possible malignant tumors, excisional biopsy is recommended to prevent cell dissemination.

Sentinel lymph node biopsy is a technique to determine if cancer has spread to the first draining lymph node. If negative, it suggests cancer has not spread further, although the presence of undetectable cancerous cells is possible.

TNM Clinical and Pathologic Classification Systems: The TNM system (T: tumor size/invasion, N: regional lymph node involvement, M: distant metastasis) is used for malignant tumors. The clinical classification (TNM) uses clinical evidence, while the pathological classification (pTNM) uses post-surgical data. This system condenses into stages (0 to IV) to indicate anatomical extent, from carcinoma in situ (Stage 0) to distant metastasis (Stage IV).

Comprehensive Treatment for Nonmelanocytic Tumors

Treatment strategies are tailored to the tumor type, size, location, and stage, often involving a combination of modalities.

Surgical Interventions: Excision and Reconstruction

Wide excision is a primary treatment, with horizontal and vertical margins varying based on tumor type. For instance, Bowen's disease or BCC may require 3-5mm margins, while malignant soft-tissue tumors might need 50mm. Mohs micrographic surgery allows for precise, continuous histological margin control during removal, minimizing tissue loss while ensuring complete tumor removal.

Lymph node dissection (e.g., axillary, inguinal) may be performed if metastasis to lymph nodes is suspected, though sentinel lymph node biopsy has reduced the need for routine dissection. Preservation of crucial nerves and vessels during dissection is paramount.

Reconstructive surgery follows tumor extirpation to repair tissue defects. While direct suturing is ideal for smaller wounds, plastic surgeons utilize a wide array of methods, including skin grafting and flap techniques. The